Mikhail A Gavrilin1,2, Christian C McAndrew2, Evan R Prather1,2, MuChun Tsai1,2, Carleen R Spitzer1,2, Min-Ae Song3,4, Srabani Mitra1,2, Anasuya Sarkar1,2, Peter G Shields4, Philip T Diaz1,2, Mark D Wewers1,2. 1. Pulmonary, Critical Care and Sleep Medicine Division, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States. 2. Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, United States. 3. College of Public Health, The Ohio State University, Columbus, OH, United States. 4. Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH, United States.
Abstract
Rationale: Caspase-1 is a zymogen whose activation predominantly depends upon the assembly of ASC monomers into insoluble prion-like polymers (specks). ASC polymers support caspase-1 dimer formation inducing a proximity mediated auto-activation of caspase-1. Therefore, the amount and nature of ASC monomers and polymers in lung bronchoalveolar lavage fluid (BALF) might serve as a marker of lung inflammasome activity. Objectives: To determine whether lung ASC concentrations or oligomerization status predicts lung function or activity of lung inflammation. Methods: BALF ASC amount and oligomerization status was studied in three distinct cohorts: (1) young healthy non-smokers, vapers and smokers; (2) healthy HIV+ smokers who underwent detailed lung function studies; and (3) hospitalized patients with suspected pneumonia. We quantified cell free BALF ASC levels by ELISA and immunoblot. Oligomers (i.e., ASC specks) were identified by chemical crosslinking and ability to sediment with centrifugation. Measurement and Main Results: ASC levels are significantly higher in lung lining fluid than in plasma as well as higher in smoker lungs compared to non-smoker lungs. In this context, ASC levels correlate with macrophage numbers, smoking intensity and loss of lung diffusion capacity in a well-characterized cohort of healthy HIV+ smokers. However, only monomeric ASC was found in our BALF samples from all subjects, including patients with lung infections. Conclusions: Even though, most, if not all, extracellular ASC in BALF exists in the soluble, monomeric form, monomeric ASC concentrations still reflect the inflammatory status of the lung microenvironment and correlate with loss of lung function.
Rationale: Caspase-1 is a zymogen whose activation predominantly depends upon the assembly of ASC monomers into insoluble prion-like polymers (specks). ASC polymers support caspase-1 dimer formation inducing a proximity mediated auto-activation of caspase-1. Therefore, the amount and nature of ASC monomers and polymers in lung bronchoalveolar lavage fluid (BALF) might serve as a marker of lung inflammasome activity. Objectives: To determine whether lung ASC concentrations or oligomerization status predicts lung function or activity of lung inflammation. Methods: BALF ASC amount and oligomerization status was studied in three distinct cohorts: (1) young healthy non-smokers, vapers and smokers; (2) healthy HIV+ smokers who underwent detailed lung function studies; and (3) hospitalized patients with suspected pneumonia. We quantified cell free BALF ASC levels by ELISA and immunoblot. Oligomers (i.e., ASC specks) were identified by chemical crosslinking and ability to sediment with centrifugation. Measurement and Main Results:ASC levels are significantly higher in lung lining fluid than in plasma as well as higher in smoker lungs compared to non-smoker lungs. In this context, ASC levels correlate with macrophage numbers, smoking intensity and loss of lung diffusion capacity in a well-characterized cohort of healthy HIV+ smokers. However, only monomeric ASC was found in our BALF samples from all subjects, including patients with lung infections. Conclusions: Even though, most, if not all, extracellular ASC in BALF exists in the soluble, monomeric form, monomeric ASC concentrations still reflect the inflammatory status of the lung microenvironment and correlate with loss of lung function.
Authors: Mikhail A Gavrilin; Dalia H A Abdelaziz; Mahmoud Mostafa; Basant A Abdulrahman; Jaykumar Grandhi; Anwari Akhter; Arwa Abu Khweek; Daniel F Aubert; Miguel A Valvano; Mark D Wewers; Amal O Amer Journal: J Immunol Date: 2012-02-24 Impact factor: 5.422
Authors: Emi Ota Machida; Malcolm V Brock; Craig M Hooker; Jun Nakayama; Akiko Ishida; Jun Amano; Maria A Picchi; Steven A Belinsky; James G Herman; Shun'ichiro Taniguchi; Stephen B Baylin Journal: Cancer Res Date: 2006-06-15 Impact factor: 12.701
Authors: Ashley A Basiorka; Kathy L McGraw; Farnoosh Abbas-Aghababazadeh; Amy F McLemore; Nicole D Vincelette; Grace A Ward; Erika A Eksioglu; David A Sallman; Najla Al Ali; Eric Padron; Javier Pinilla-Ibarz; Rami Komrokji; Erico Masala; Valeria Santini; Olivier Kosmider; Michaela Fontenay; Pierre Fenaux; Lubomir Sokol; Sheng Wei; Brooke Fridley; Alan F List Journal: Lancet Haematol Date: 2018-07-30 Impact factor: 18.959
Authors: Mohammed G Ghonime; Obada R Shamaa; Ramadan A Eldomany; Mikhail A Gavrilin; Mark D Wewers Journal: Biochem Biophys Res Commun Date: 2012-07-27 Impact factor: 3.575
Authors: Mikhail A Gavrilin; Evan R Prather; Alex D Vompe; Christian C McAndrew; Mark D Wewers Journal: J Immunol Date: 2021-02-10 Impact factor: 5.422
Authors: Lichchavi D Rajasinghe; Preeti S Chauhan; Kathryn A Wierenga; Augustus O Evered; Shamya N Harris; Melissa A Bates; Mikhail A Gavrilin; James J Pestka Journal: Front Immunol Date: 2020-10-06 Impact factor: 7.561